A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.
Around 30% of the population suffers from dry skin, and I’m definitely among them — especially in the brutally cold winter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback